Study Human Immunodeficiency Virus-1 Protease Inhibitors

Sadler BM, Gillotin C, Lou Y, Eron JJ, Lang W, Haubrich R, Stein DS. Pharmacokinetic study of human immunodeficiency virus protease inhibitors used in combination with amprenavir. Antimicrob Agents Chemother 2001 45(12) 3663-8. 

Waller, C. L., Oprea, T. I., Giolitti, A., and Marshall, G. R. (1993) Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A COMFA study employing experimentally-determined alignement rules../. Med. Chem. 36, 4152-4160. 

Mueller BU, Nelson RP Jr, Sleasman J, Zuckerman J, Heath-Chiozzi M, Steinberg SM, Bahs FM, Brouwers P, Hsu A, Saulis R, Sei S, Wood LV, Zeichner S, Katz TT, Higham C, Aker D, Edgerly M, Jarosinski P, Serchuck L, Whitcup SM, Pizzuti D, Pizzo PA. A phase FII study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection. Pediatrics 1998 101(3 Pt 1) 335 3. 

C. L. Waller, T. I. Oprea, A. Giolitti, and G. R. Marshall,/. Med. Chem., 36, 4152 (1993). 3-D QSAR of Human Immunodeficiency Virus (1) Protease Inhibitors. I. A CoMFA Study Employing Experimentally Determined Alignment Rules. 

---